Unilateral ureteral obstruction: Beyond obstruction

International Urology and Nephrology

Volumn 46, Issue 4, 2014, Pages 765-776

  Ucero, Alvaro C ^a   Benito Martin, Alberto ^a   Izquierdo, Maria C ^a   Sanchez Niño, Maria D ^c   Sanz, Ana B ^a   Ramos, Adrian M ^a   Berzal, Sergio ^a   Ruiz Ortega, Marta ^a,b   Egido, Jesus ^a,b   Ortiz, Alberto ^a,b,d  

^a UAM)   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^d Section of Nephrology   (Spain)

Author keywords

Acute kidney injury; Apoptosis; Chronic kidney disease; Fibrosis; Inflammation; Kidney

Indexed keywords

ACTIVIN; ACTIVIN LIKE KINASE 3; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; BRADYKININ B1 RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR7; COLONY STIMULATING FACTOR 1; CYCLIN DEPENDENT KINASE; DIPEPTIDYL CARBOXYPEPTIDASE; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; HUMAN EPIDIDYMIS PROTEIN 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOTOXIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OSTEOGENIC PROTEIN 1; OSTEOPONTIN; PARICALCITOL; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN P53; SECONDARY LYMPHOID TISSUE CHEMOKINE; SMAD3 PROTEIN; SMAD7 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; APOPTOSIS; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DAMAGE; CHRONIC KIDNEY DISEASE; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSING ALVEOLITIS; INFLAMMATION; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; NONHUMAN; REVIEW; UNILATERAL URETERAL OBSTRUCTION; URETER OBSTRUCTION; URINARY TRACT OBSTRUCTION; ACUTE KIDNEY INJURY; ANIMAL; COMPLICATION; DISEASE MODEL; FIBROSIS; HUMAN; KIDNEY; METABOLISM; MOLECULARLY TARGETED THERAPY; MOUSE; NEPHRITIS, INTERSTITIAL; PATHOLOGY; RAT; RENAL INSUFFICIENCY, CHRONIC;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; FIBROSIS; HUMANS; KIDNEY; MICE; MOLECULAR TARGETED THERAPY; NEPHRITIS, INTERSTITIAL; RATS; RENAL INSUFFICIENCY, CHRONIC; URETERAL OBSTRUCTION;

EID: 84897510989     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0520-1     Document Type: Review

References (134)

1. Better OS, Arieff AI, Massry SG, Kleeman CR, Maxwell MH (1973) Studies on renal function after relief of complete unilateral ureteral obstruction of three months' duration in man. Am J Med 54:234-240
2. Sacks SH, Aparicio SA, Bevan A, Oliver DO, Will EJ, Davison AM (1989) Late renal failure due to prostatic outflow obstruction: a preventable disease. BMJ 298:156-159
3. Ucero AC, Benito-Martin A, Fuentes-Calvo I et al (2013) TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast. Biochim Biophys Acta 1832(10):1744-1755
4. Ulm AH, Miller F (1962) An operation to produce experimental reversible hydronephrosis in dogs. J Urol 88:337-341
5. Shokeir AA (1995) Partial ureteral obstruction: a new variable and reversible canine experimental model. Urology 45:953-957
6. Wen JG, Frokiaer J, Zhao JB, Ringgaard S, Jorgensen TM, Djurhuus JC (2002) Severe partial ureteric obstruction in newborn rats can produce renal dysplasia. BJU Int 89:740-745
7. Josephson S, Jacobsson E, Larsson E (1997) Experimental partial ureteric obstruction in newborn rats. IX. Renal morphology and function after 1 year of obstruction. Urol Int 59:16-22
8. Eskild-Jensen A, Frøkiaer J, Djurhuus JC, Jørgensen TM, Nyengaard JR (2002) Reduced number of glomeruli in kidneys with neonatally induced partial ureteropelvic obstruction in pigs. J Urol 167:1435-1439
9. Chevalier RL, Kaiser DL (1984) Chronic partial ureteral obstruction in the neonatal guinea pig. I. Influence of uninephrectomy on growth and hemodynamics. Pediatr Res 18:1266-1271
10. Chevalier RL (1984) Chronic partial ureteral obstruction in the neonatal guinea pig. II. Pressure gradients affecting glomerular filtration rate. Pediatr Res 18:1271-1277
11. Eskild-Jensen A, Paulsen LF, Wogensen L et al (2007) AT1 receptor blockade prevents interstitial and glomerular apoptosis but not fibrosis in pigs with neonatal induced partial unilateral ureteral obstruction. Am J Physiol Renal Physiol 292:F1771-F1781
12. Puri TS, Shakaib MI, Chang A et al (2010) Chronic kidney disease induced in mice by reversible unilateral ureteral obstruction is dependent on genetic background. Am J Physiol Renal Physiol 298:F1024-F1032
13. Chaabane W, Praddaude F, Buleon M et al (2013) Renal functional decline and glomerulotubular injury are arrested but not restored by release of unilateral ureteral obstruction (UUO). Am J Physiol Renal Physiol 304:F432-F439
14. Harris K, Klahr S, Schreiner G (1993) Obstructive nephropathy: from mechanical disturbance to immune activation?. Exp Nephrol 1:198-204
15. Klahr S (1991) Pathophysiology of obstructive nephropathy: a 1991 update. Semin Nephrol 11:156-168
16. Wen JG, Frøkiaer J, Jørgensen TM, Djurhuus JC (1999) Obstructive nephropathy: an update of the experimental research. Urol Res 27:29-39
17. Diamond JR, Kees-Folts D, Ricardo SD, Pruznak A, Eufemio M (1995) Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol 146:1455-1466
18. Yoo KH, Thornhill BA, Forbes MS et al (2006) Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction. Kidney Int 70:1735-1741
19. Schreiner GF, Harris KP, Purkerson ML, Klahr S (1988) Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int 34:487-493
20. Vielhauer V, Anders HJ, Mack M et al (2001) Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J Am Soc Nephrol 12:1173-1187
21. Duymelinck C, Dauwe SE, De Greef KE, Ysebaert DK, Verpooten GA, De Broe ME (2000) TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat. Kidney Int 58:1186-1201
22. Misseri R, Meldrum DR, Dagher P, Hile K, Rink RC, Meldrum KK (2004) Unilateral ureteral obstruction induces renal tubular cell production of tumor necrosis factor-Alpha independent of inflammatory cell infiltration. J Urol 172:1595-1599
23. Meldrum KK, Metcalfe P, Leslie JA, Misseri R, Hile KL, Meldrum DR (2006) TNF-Alpha neutralization decreases nuclear factor-kappaB activation and apoptosis during renal obstruction. J Surg Res 131:182-188
24. Morrissey JJ, Klahr S (1997) Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction. Kidney Int 52:926-933
25. Morrissey JJ, Klahr S (1999) Effect of AT2 receptor blockade on the pathogenesis of renal fibrosis. Am J Physiol 276:F39-F45
26. Sanz AB, Sanchez-Nino MD, Ramos AM et al (2010) NF-kappaB in renal inflammation. J Am Soc Nephrol 21:1254-1262
27. Ricardo SD, Levinson ME, DeJoseph MR, Diamond JR (1996) Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. Kidney Int 50:2002-2010
28. Morrissey JJ, Klahr S (1998) Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis. Am J Physiol 274:F580-F586
29. Le Meur Y, Tesch GH, Hill PA et al (2002) Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway. J Leukoc Biol 72:530-537
30. Kaneto H, Ohtani H, Fukuzaki A et al (1999) Increased expression of TGF-beta1 but not of its receptors contributes to human obstructive nephropathy. Kidney Int 56:2137-2146
31. Ricardo SD, van GH, Eddy AA (2008) Macrophage diversity in renal injury and repair. J Clin Invest 118:3522-3530
32. Liu L, Kou P, Zeng Q et al (2012) CD4 + T Lymphocytes, especially Th2 cells, contribute to the progress of renal fibrosis. Am J Nephrol 36:386-396
33. Pindjakova J, Hanley SA, Duffy MM et al (2012) Interleukin-1 accounts for intrarenal Th17 cell activation during ureteral obstruction. Kidney Int 81:379-390
34. Bige N, Shweke N, Benhassine S et al (2012) Thrombospondin-1 plays a profibrotic and pro-inflammatory role during ureteric obstruction. Kidney Int 81:1226-1238
35. Gao B, Waisman A (2012) Th17 cells regulate liver fibrosis by targeting multiple cell types: many birds with one stone. Gastroenterology 143:536-539
36. Tan HL, Regamey N, Brown S, Bush A, Lloyd CM, Davies JC (2011) The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med 184:252-258
37. Ortiz A, Justo P, Sanz A, Lorz C, Egido J (2003) Targeting apoptosis in acute tubular injury. Biochem Pharmacol 66:1589-1594
38. Linkermann A, Bräsen JH, Himmerkus N et al (2012) Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 81:751-761
39. Sanz AB, Santamaría B, Ruiz-Ortega M, Egido J, Ortiz A (2008) Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol 19:1634-1642
40. Ardura JA, Berruguete R, Ramila D, Alvarez-Arroyo MV, Esbrit P (2008) Parathyroid hormone-related protein interacts with vascular endothelial growth factor to promote fibrogenesis in the obstructed mouse kidney. Am J Physiol Renal Physiol 295:F415-F425
41. Ortega A, Rámila D, Ardura JA et al (2006) Role of parathyroid hormone-related protein in tubulointerstitial apoptosis and fibrosis after folic acid-induced nephrotoxicity. J Am Soc Nephrol 17:1594-1603
42. Degterev A, Huang Z, Boyce M et al (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1:112-119
43. Choi YJ, Baranowska-Daca E, Nguyen V et al (2000) Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules. Kidney Int 58:1481-1491
44. Gobe GC, Axelsen RA (1987) Genesis of renal tubular atrophy in experimental hydronephrosis in the rat Role of apoptosis. Lab Invest 56:273-281
45. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341-350
46. Humphreys BD, Lin SL, Kobayashi A et al (2010) Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176:85-97
47. Zeisberg M, Duffield JS (2010) Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21:1247-1253
48. Misaki T, Yamamoto T, Suzuki S et al (2009) Decrease in tumor necrosis factor-Alpha receptor-Associated death domain results from ubiquitin-dependent degradation in obstructive renal injury in rats. Am J Pathol 175:74-83
49. Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV (2010) Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16(535-543):531p
50. Jones EA, Shahed A, Shoskes DA (2000) Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction. Urology 56:346-351
51. Ortiz A, Lorz C, Egido J (1999) The Fas ligand/Fas system in renal injury. Nephrol Dial Transplant 14:1831-1834
52. Lorz C, Ortiz A, Justo P et al (2000) Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol 11:1266-1277
53. Lange-Sperandio B, Fulda S, Vandewalle A, Chevalier R (2003) Macrophages induce apoptosis in proximal tubule cells. Pediatr Nephrol 18:335-341
54. Grande MT, López-Novoa JM (2009) Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol 5:319-328
55. Matsuo S, López-Guisa J, Cai X et al (2005) Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice. Kidney Int 67:2221-2238
56. Eddy AA, López-Guisa JM, Okamura DM, Yamaguchi I (2012) Investigating mechanisms of chronic kidney disease in mouse models. Pediatr Nephrol 27:1233-1247
57. Strutz F, Zeisberg M (2006) Renal fibroblasts and myofibroblast in chronic kidney disease. J Am Soc Nephrol 17:2992-2998
58. Qi W, Chen X, Poronnik P, Pollock CA (2006) The renal cortical fibroblast in renal tubulointerstitial fibrosis. Int J Biochem Cell Biol 38:1-5
59. Strutz F (2008) How many different roads may a cell walk down in order to become a fibroblast? J Am Soc Nephrol 19:2246-2248
60. Lin SL, Kisseleva T, Brenner DA, Duffield JS (2008) Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 173:1617-1627
61. Sakai N, Wada T, Yokoyama H et al (2006) Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA 103:14098-14103
62. Epstein JB, McCarthy GM (1996) Progress in HIV and AIDS care. J Can Dent Assoc 62:866-867
63. Lee DB, Huang E, Ward HJ (2006) Tight junction biology and kidney dysfunction. Am J Physiol Renal Physiol 290:F20-F34
64. Sanz AB, Sanchez-Nino MD, Izquierdo MC et al (2010) TWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21. PLoS One 5:e8955
65. Lange-Sperandio B, Trautmann A, Eickelberg O et al (2007) Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. Am J Pathol 171:861-871
66. Martinez-Salgado C, Fuentes-Calvo I, Garcia-Cenador B, Santos E, Lopez-Novoa JM (2006) Involvement of H- and N-Ras isoforms in transforming growth factor-beta1-induced proliferation and in collagen and fibronectin synthesis. Exp Cell Res 312:2093-2106
67. Grande MT, Fuentes-Calvo I, Arevalo M et al (2010) Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice. Kidney Int 77:509-518
68. Bechtel W, McGoohan S, Zeisberg EM et al (2010) Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 16:544-550
69. Park SJ, Jeong KS (2004) Cell-type-specific activation of mitogen-Activated protein kinases in PAN-induced progressive renal disease in rats. Biochem Biophys Res Commun 323:1-8
70. Pat B, Yang T, Kong C, Watters D, Johnson DW, Gobe G (2005) Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int 67:931-943
71. Han Y, Masaki T, Hurst LA et al (2008) Extracellular signal-regulated kinase-dependent interstitial macrophage proliferation in the obstructed mouse kidney. Nephrology (Carlton) 13:411-418
72. Jin Y, Ratnam K, Chuang PY et al (2012) A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nat Med 18:580-588
73. Zhang Y, Kong J, Deb DK, Chang A, Li YC (2010) Vitamin D receptor attenuates renal fibrosis by suppressing the renin-Angiotensin system. J Am Soc Nephrol 21:966-973
74. Ruiz-Ortega M, Ruperez M, Esteban V et al (2006) Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 21:16-20
75. Wolf G, Mueller E, Stahl RA, Ziyadeh FN (1993) Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. J Clin Invest 92:1366-1372
76. Shin GT, Kim WH, Yim H, Kim MS, Kim H (2005) Effects of suppressing intrarenal angiotensinogen on renal transforming growth factor-beta1 expression in acute ureteral obstruction. Kidney Int 67:897-908
77. Lavoz C, Rodrigues-Diez R, Benito-Martin A et al (2012) Angiotensin II contributes to renal fibrosis independently of Notch pathway activation. PLoS One 7:e40490
78. Fern RJ, Yesko CM, Thornhill BA, Kim HS, Smithies O, Chevalier RL (1999) Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest 103:39-46
79. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S (1995) Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47:1285-1294
80. Ishidoya S, Morrissey J, McCracken R, Klahr S (1996) Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 49:1110-1119
81. Klahr S, Ishidoya S, Morrissey J (1995) Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis 26:141-146
82. Moridaira K, Morrissey J, Fitzgerald M et al (2003) ACE inhibition increases expression of the ETB receptor in kidneys of mice with unilateral obstruction. Am J Physiol Renal Physiol 284:F209-F217
83. Esteban V, Lorenzo O, Rupérez M et al (2004) Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol 15:1514-1529
84. Klahr S, Morrissey JJ (2000) The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int Suppl 75:S7-S14
85. Satoh M, Kashihara N, Yamasaki Y et al (2001) Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 12:317-325
86. Ma J, Nishimura H, Fogo A, Kon V, Inagami T, Ichikawa I (1998) Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int 53:937-944
87. Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S (1994) Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 45:1637-1647
88. Ferrario CM (2002) Angiotensin I, angiotensin II and their biologically active peptides. J Hypertens 20:805-807
89. Esteban V, Ruperez M, Sánchez-L¢pez E et al (2005) Angiotensin IV activates the nuclear transcription factor-kappa B and related proinflammatory genes in vascular smooth muscle cells. Circ Res 96:965-973
90. Esteban V, Heringer-Walther S, Sterner-Kock A et al (2009) Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation. PLoS One 4:e5406
91. Tan X, Li Y, Liu Y (2006) Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 17:3382-3393
92. Miyajima A, Chen J, Lawrence C et al (2000) Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58:2301-2313
93. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A (2003) Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112:1486-1494
94. Inazaki K, Kanamaru Y, Kojima Y et al (2004) Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney Int 66:597-604
95. Lan HY, Mu W, Tomita N et al (2003) Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 14:1535-1548
96. Hruska KA, Guo G, Wozniak M et al (2000) Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 279:F130-F143
97. Sugiura H, Yoshida T, Shiohira S et al (2012) Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis. Am J Physiol Renal Physiol 302:F1252-F1264
98. Zhou L, Li Y, Zhou D, Tan RJ, Liu Y (2013) Loss of Klotho Contributes to Kidney Injury by Derepression of Wnt/β-Catenin Signaling. J Am Soc Nephrol 24:771-785
99. Satoh M, Nagasu H, Morita Y, Yamaguchi TP, Kanwar YS, Kashihara N (2012) Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling. Am J Physiol Renal Physiol 303:F1641-F1651
100. Moreno JA, Izquierdo MC, Sanchez-Niño MD et al (2011) The inflammatory cytokines TWEAK and TNFα reduce renal Klotho expression through NFκB. J Am Soc Nephrol 22:1315-1325
101. Izquierdo MC, Sanz AB, Sánchez-Niño MD et al (2012) Acute kidney injury transcriptomics unveils a relationship between inflammation and ageing. Nefrologia 32:715-723
102. Izquierdo MC, Perez-Gomez MV, Sanchez-Niño MD et al (2012) Klotho, phosphate and inflammation/ageing in chronic kidney disease. Nephrol Dial Transplant 27(Suppl 4):iv6-iv10
103. Sugimoto H, Lebleu VS, Bosukonda D et al (2012) Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat Med 18:396-404
104. Mazzieri R, Masiero L, Zanetta L et al (1997) Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J 16:2319-2332
105. Ishidoya S, Ogata Y, Fukuzaki A, Kaneto H, Takeda A, Orikasa S (2002) Plasminogen activator inhibitor-1 and tissue-type plasminogen activator are up-regulated during unilateral ureteral obstruction in adult rats. J Urol 167:1503-1507
106. Yang J, Shultz RW, Mars WM et al (2002) Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 110:1525-1538
107. Oda T, Jung YO, Kim HS et al (2001) PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 60:587-596
108. Lebleu VS, Teng Y, O'Connell JT et al (2013) Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med 19:227-231
109. Kitagawa K, Wada T, Furuichi K et al (2004) Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 165:237-246
110. Tsou CL, Peters W, Si Y et al (2007) Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 117:902-909
111. Eis V, Luckow B, Vielhauer V et al (2004) Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol 15:337-347
112. Anders HJ, Vielhauer V, Frink M et al (2002) A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest 109:251-259
113. Klein J, Gonzalez J, Duchene J et al (2009) Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy. FASEB J 23:134-142
114. Miyajima A, Kosaka T, Seta K, Asano T, Umezawa K, Hayakawa M (2003) Novel nuclear factor kappa B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction. J Urol 169:1559-1563
115. Kim KH, Lee ES, Cha SH et al (2009) Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy. Exp Mol Pathol 86:114-120
116. Ophascharoensuk V, Fero ML, Hughes J, Roberts JM, Shankland SJ (1998) The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nat Med 4:575-580
117. Hegarty NJ, Young LS, O'Neill AJ, Watson RW, Fitzpatrick JM (2003) Endothelin in unilateral ureteral obstruction: vascular and cellular effects. J Urol 169:740-744
118. Zhong X, Chung AC, Chen HY, Meng XM, Lan HY (2011) Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 22:1668-1681
119. Lino Cardenas CL, Henaoui IS, Courcot E et al (2013) miR-199a-5p is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting Caveolin-1. PLoS Genet 9:e1003291
120. Chung AC, Huang XR, Meng X, Lan HY (2010) miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol 21:1317-1325
121. Wang B, Komers R, Carew R et al (2012) Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol 23:252-265
122. Qin W, Chung AC, Huang XR et al (2011) TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 22:1462-1474
123. Chau BN, Xin C, Hartner J, et al. (2012) MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med 4:121ra118
124. Sanchez-Niño MD, Ortiz A (2012) Notch3 and kidney injury: never two without three. J Pathol 228:266-273
125. Liu N, Guo JK, Pang M et al (2012) Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis. J Am Soc Nephrol 23:854-867
126. Bozic M, de Rooij J, Parisi E, Ortega MR, Fernandez E, Valdivielso JM (2011) Glutamatergic signaling maintains the epithelial phenotype of proximal tubular cells. J Am Soc Nephrol 22:1099-1111
127. Hao S, He W, Li Y et al (2011) Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol 22:1642-1653
128. Ophascharoensuk V, Giachelli CM, Gordon K et al (1999) Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56:571-580
129. Zoja C, Corna D, Gagliardini E et al (2010) Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection. Am J Physiol Renal Physiol 299:F1203-F1211
130. Guo G, Morrissey J, McCracken R, Tolley T, Klahr S (1999) Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol 277:F766-F772
131. Kim J, Padanilam BJ (2013) Renal nerves drive interstitial fibrogenesis in obstructive nephropathy. J Am Soc Nephrol 24:229-242
132. Ortiz A, Ucero AC, Egido J (2010) Unravelling fibrosis: two newcomers and an old foe. Nephrol Dial Transplant 25:3492-3495
133. El Chaar M, Chen J, Seshan SV et al (2007) Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction. Am J Physiol Renal Physiol 292:F1291-F1301
134. Álvarez-Prats A, Hernández-Perera O, Díaz-Herrera P et al (2012) Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy. Nephrol Dial Transplant 27:2720-2733